Valuation: CareDx, Inc.

Market Cap 4.44B 3.98B 3.67B 3.33B 6.3B 416B 6.48B 43.9B 17.49B 223B 16.65B 16.29B 704B P/E 2026 *
33.6x
P/E 2027 * 137x
Enterprise Value 4.44B 3.98B 3.67B 3.33B 6.3B 416B 6.48B 43.9B 17.49B 223B 16.65B 16.29B 704B EV / Sales 2026 *
8.45x
EV / Sales 2027 * 7.75x
Free-Float
97%
Yield 2026 *
-
Yield 2027 * -
1 day-4.63%
1 week-8.90%
Current month-7.79%
1 month+27.69%
3 months+71.23%
6 months+274.01%
Current year+327.81%
1 week 75.81
Extreme 75.81
89.85
1 month 61.34
Extreme 61.34
90.87
Current year 15.56
Extreme 15.56
90.87
1 year 15.15
Extreme 15.15
90.87
3 years 7.09
Extreme 7.09
90.87
5 years 4.8
Extreme 4.8
90.87
10 years 0.76
Extreme 0.76
99.83
Manager TitleAgeSince
Chief Executive Officer 46 15/04/2024
Director of Finance/CFO 56 26/02/2026
Chief Tech/Sci/R&D Officer - 01/10/2025
Director TitleAgeSince
Chairman 68 01/11/2021
Chairman 59 01/01/2020
Director/Board Member 70 08/04/2014
Date Insider Type Main position Quantity % Market Cap. Importance
03/11/26 Don

Director

-25,000 0.0483%
01/11/26 Tax

General Counsel

-2,873 0.0056%
02/10/26 Free

Chairman

588 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-4.63%-8.90%+382.63%+987.72% 4.44B
+0.01%+8.40%+58.48%+69.01% 68.22B
+1.22%+9.56%+15.97%+90.23% 59.82B
+0.24%+1.35%+23.78%+97.55% 56.07B
+1.13%+18.81%+28.13%+111.84% 47.67B
-1.31%+4.94%+29.35%+40.61% 45.95B
-3.79%-1.26%+205.73%+873.03% 43.29B
-3.33%+5.73%+23.28%+47.32% 35.66B
-2.19%-3.71%+90.94%+66.33% 34.73B
+2.23%+13.35%-38.32%+398.44% 25.47B
Average -1.04%+4.59%+82.00%+278.21% 42B
Weighted average by Cap. -0.57%+4.98%+53.60%+187.71%

Financials

2026 *2027 *
Net sales 525M 471M 434M 394M 746M 49.21B 766M 5.19B 2.07B 26.37B 1.97B 1.93B 83.35B 572M 513M 473M 430M 813M 53.67B 836M 5.67B 2.26B 28.76B 2.15B 2.1B 90.91B
Net income 139M 125M 115M 104M 198M 13.04B 203M 1.38B 549M 6.99B 522M 511M 22.09B 33.85M 30.36M 27.98M 25.41M 48.09M 3.17B 49.43M 335M 133M 1.7B 127M 124M 5.38B
Net Debt - -
Projected Income Statement - Annual - CareDx, Inc.
Logo CareDx, Inc.
CareDx, Inc. is a precision medicine diagnostics company advancing care in transplant, specialty oncology, and cell therapy. Through non-invasive longitudinal molecular biomarker testing, digital health, and patient support solutions, the Company is focused on improving patient outcomes. The Company's integrated solutions include non-invasive molecular testing for heart, kidney, and lung transplants; digital health technologies; and patient solutions that support care before and after transplant. The Company also provides genomic-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients.
Employees
763
Date Price Change Volume
11/11/26 $80.60 -4.52% 659,286
09/11/26 $84.42 +7.46% 1,094,624
06/11/26 $78.56 +2.92% 1,126,412
05/11/26 $76.33 -11.10% 2,062,084
04/11/26 $85.86 -2.95% 1,458,394
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
MarketScreener Ratings - CareDx, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
84.42USD
Average target price
93.50USD
Spread / Average Target
+10.76%
  1. Stock Market
  2. Stocks
  3. CDNA Stock